D017778Chemicals & DrugsD20.215.894.815330.999112Vaccines, CombinedFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonMicrobiology and ImmunologyPediatricsWake Forest School of MedicineKarenHaasKaren M. Haas PhD36.08919100000000-80.26677800000000539Haas, KarenAssociate ProfessorThomasWierzbaThomas F. Wierzba PhD, MS, MPH2349Wierzba, ThomasProfessor20Professor28987444Walker RI, Wierzba TF, Mani S, Bourgeois ALVaccineWalker RI, Wierzba TF, Mani S, Bourgeois AL. Vaccines against Shigella and enterotoxigenic Escherichia coli: A summary of the 2016 VASE Conference. Vaccine. 2017 12 14; 35(49 Pt A):6775-6782.Vaccine2017-10-04T00:00:002017Vaccines against Shigella and enterotoxigenic Escherichia coli: A summary of the 2016 VASE Conference.Internal Medicine, Infectious DiseasesLindsayThompsonLindsay A. Thompson3244Thompson, LindsayProfessor16940842Thompson LA, Irigoyen M, Matiz LA, LaRussa PS, Chen S, Chimkin FThe Pediatric infectious disease journalThompson LA, Irigoyen M, Matiz LA, LaRussa PS, Chen S, Chimkin F. The impact of DTaP-IPV-HB vaccine on use of health services for young infants. Pediatr Infect Dis J. 2006 Sep; 25(9):826-31.Pediatr Infect Dis J2006-09-01T00:00:002006The impact of DTaP-IPV-HB vaccine on use of health services for young infants.true1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessor15128761Haas KM, Toapanta FR, Oliver JA, Poe JC, Weis JH, Karp DR, Bower JF, Ross TM, Tedder TFJournal of immunology (Baltimore, Md. : 1950)Haas KM, Toapanta FR, Oliver JA, Poe JC, Weis JH, Karp DR, Bower JF, Ross TM, Tedder TF. Cutting edge: C3d functions as a molecular adjuvant in the absence of CD21/35 expression. J Immunol. 2004 May 15; 172(10):5833-7.J Immunol2004-05-15T00:00:002004Cutting edge: C3d functions as a molecular adjuvant in the absence of CD21/35 expression.0.07428590.04006083research area of0.1603860.0634083subject area for